Drugs / Imovax Rabies Vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 1 | NCT00308061 Comparator | Jul 2003 → Sep 2004 | malaria | U.S. Army Medical Research and Development Command | Completed | No outcome recorded |
| Phase 1 | NCT00317473 Comparator | Jun 2003 → Jul 2004 | Plasmodium falciparum malaria | U.S. Army Medical Research and Development Command | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Imovax Rabies vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00317473 ↗ |
| Modality | Vaccine | “Imovax Rabies vaccine” NCT00317473 ↗ |
| Route | Intramuscular | “1 mL of Imovax Rabies Vaccine is given to subject on days 0, 30+7, and 60+7 in the left deltoid muscle” NCT00308061 ↗ |